OraSure Technologies Inc (NAS:OSUR)
$ 4.85 -0.07 (-1.42%) Market Cap: 358.70 Mil Enterprise Value: 107.92 Mil PE Ratio: 16.17 PB Ratio: 0.84 GF Score: 79/100

OraSure Technologies Inc at UBS Global Healthcare Conference Transcript

May 22, 2019 / 01:30PM GMT
Release Date Price: $8.39 (-0.94%)
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

So listen, welcome. Day 3 UBS Global Healthcare Conference. Pleased to be joined on stage -- with me is the senior management team of OraSure. My name is Dan Brennan. I cover tools, diagnostics and pharma services. Before we start, I'll direct you to the UBS website at www.ubs.com for all the relevant analyst disclaimer information. So with me to my left is Steve Tang, President and CEO. And to his left is Roberto, and I apologize...

Roberto E. Cuca
OraSure Technologies, Inc. - CFO & Principal Accounting Officer

Cuca.

Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Cuca. I wanted to make sure I had that correct -- who's the Chief Financial Officer. I think Steve's going to go through a series of slides. And then afterwards, we'll have a fireside with a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot